Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Jingwei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4595-584X; OpenAlex author ID A5147629254. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. FNDC4 Drives Metastasis and Immune Evasion in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-1001↗
  2. H19 promotes polarization and alternative splicing in tumor-associated macrophages, facilitating pancreatic cancer progression. Co-author DOI 10.1016/j.canlet.2024.217389↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chenlei Wen · 2 shared papers, 2025–2026 · strength 0.45
  2. Baiyong Shen · 2 shared papers, 2025–2026 · strength 0.45
  3. Yu Jiang · 1 shared paper, 2026 · strength 0.24
  4. Berina Šabanović · 1 shared paper, 2026 · strength 0.24
  5. Miriam Roberto · 1 shared paper, 2026 · strength 0.24
  6. Yuntao YANG · 1 shared paper, 2026 · strength 0.24
  7. Christopher Heeschen · 1 shared paper, 2026 · strength 0.24
  8. Jiayu Lin · 1 shared paper, 2025 · strength 0.21
  9. Yizhi Cao · 1 shared paper, 2025 · strength 0.21
  10. Shuyu Zhai · 1 shared paper, 2025 · strength 0.21
  11. Pengyi Liu · 1 shared paper, 2025 · strength 0.21
  12. Yishu Huang · 1 shared paper, 2025 · strength 0.21
  13. Yang Liu · 1 shared paper, 2025 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.